Cargando…

Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism

OBJECTIVE—Adiponectin is an adipocyte-derived hormone that plays an important role in glucose and lipid metabolism. The main aims of this study are to investigate the effects of adiponectin on VLDL triglyceride (VLDL-TG) metabolism and the underlying mechanism. RESEARCH DESIGN AND METHODS—Adenovirus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Liping, Zou, Chenhui, van der Westhuyzen, Deneys R., Shao, Jianhua
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2008
Materias:	Obesity Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453618/ https://www.ncbi.nlm.nih.gov/pubmed/18375436 http://dx.doi.org/10.2337/db07-0435

Ejemplares similares

Adiponectin Inhibits Lipolysis in Mouse Adipocytes
por: Qiao, Liping, et al.
Publicado: (2011)

Adiponectin Increases Skeletal Muscle Mitochondrial Biogenesis by Suppressing Mitogen-Activated Protein Kinase Phosphatase-1
por: Qiao, Liping, et al.
Publicado: (2012)

Adiponectin Enhances Mouse Fetal Fat Deposition
por: Qiao, Liping, et al.
Publicado: (2012)

Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome
por: Broedl, Uli C, et al.
Publicado: (2006)

Mediation effect of obesity on the association between triglyceride‐glucose index and hyperuricemia in Chinese hypertension adults
por: Sun, Jin, et al.
Publicado: (2021)

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2014)

Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?
por: Bitzur, Rafael, et al.
Publicado: (2009)

Maternal High-Fat Feeding Increases Placental Lipoprotein Lipase Activity by Reducing SIRT1 Expression in Mice
por: Qiao, Liping, et al.
Publicado: (2015)

Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2015)

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis
por: Whitacre, Brynne E., et al.
Publicado: (2021)

Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides
por: Rayner, Katey J., et al.
Publicado: (2011)

Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation
por: Takahashi, Sadao
Publicado: (2017)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Gene-environment interactions due to quantile-specific heritability of triglyceride and VLDL concentrations
por: Williams, Paul T.
Publicado: (2020)

Prolonged Prepregnant Maternal High-Fat Feeding Reduces Fetal and Neonatal Blood Glucose Concentrations by Enhancing Fetal β-Cell Development in C57BL/6 Mice
por: Qiao, Liping, et al.
Publicado: (2019)

Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment
por: Samson, Clarissa E., et al.
Publicado: (2012)

LncRP11-675F6.3 responds to rapamycin treatment and reduces triglyceride accumulation via interacting with HK1 in hepatocytes by regulating autophagy and VLDL-related proteins: LncRNA with HK1 regulates triglycerides, autophagy and VLDL
por: Wang, Lingling, et al.
Publicado: (2023)

PMON31 IL-4 Serum Levels Correlate with Triglycerides and VLDL in African American males
por: Johnson, Abraham, et al.
Publicado: (2022)

Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers
por: Ramirez, Vanessa I, et al.
Publicado: (2014)

DsbA-L Alleviates Endoplasmic Reticulum Stress–Induced Adiponectin Downregulation
por: Zhou, Lijun, et al.
Publicado: (2010)

The Relation between Erythrocyte Trans Fat and Triglyceride, VLDL- and HDL-Cholesterol Concentrations Depends on Polyunsaturated Fat
por: Kabagambe, Edmond K., et al.
Publicado: (2012)

Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes
por: Carlier, Aurélie, et al.
Publicado: (2020)

Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
por: Zhang, Bai-Hui, et al.
Publicado: (2022)

Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration
por: Ryu, Jiyoon, et al.
Publicado: (2021)

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
por: Bruinstroop, Eveline, et al.
Publicado: (2012)

Adipose triglyceride lipase–mediated lipid catabolism is essential for bronchiolar regeneration
por: Kanti, Manu Manjunath, et al.
Publicado: (2022)

OR20-3 The Relationship of Obesity Severity, Triglycerides, and Elevated ALT Levels in Adolescents
por: Wu, Stephanie, et al.
Publicado: (2019)

Fat-Specific DsbA-L Overexpression Promotes Adiponectin Multimerization and Protects Mice From Diet-Induced Obesity and Insulin Resistance
por: Liu, Meilian, et al.
Publicado: (2012)

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
por: Heebøll, Sara, et al.
Publicado: (2022)

Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects
por: Di Filippo, Mathilde, et al.
Publicado: (2014)

JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs
por: Aggarwal, Dimple, et al.
Publicado: (2005)

Correction: Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects
Publicado: (2014)

Type 2 Diabetes Mellitus Remission in Obese Patients Under Bariatric Surgery: The Role of Preoperative Triglycerides Levels
por: Gonçalves, Vanessa Guerreiro, et al.
Publicado: (2021)

Macrophages take up VLDL-sized emulsion particles through caveolae-mediated endocytosis and excrete part of the internalized triglycerides as fatty acids
por: Deng, Lei, et al.
Publicado: (2022)

Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation
por: Lin, Huige, et al.
Publicado: (2022)

The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels
por: Zhang, Ren
Publicado: (2021)

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
por: Wieczorek, Ewa, et al.
Publicado: (2021)

The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL
por: van Dijk, Peter R., et al.
Publicado: (2019)

Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
por: Green, Charlotte J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9a3p9prso8au0f40homvbnv2ke